日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer

探索性生物标志物在转移性微卫星稳定型结直肠癌中对奥沙利铂诱导的纳武利尤单抗反应性的影响

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-026-03357-6
Ree, Anne Hansen; Bousquet, Paula A; Visnovska, Tina; Lüders, Torben; Geisler, Benjamin P; Wang, Shixiong; Bordin, Diana L; Nilsen, Hilde L; Hamre, Hanne M; Kersten, Christian; Hofsli, Eva; Guren, Marianne G; Sorbye, Halfdan; Berg, Jens P; Flatmark, Kjersti; Meltzer, Sebastian
肿瘤
肠癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Molecular-clinical characteristics and treatment outcomes in 163 metastatic colorectal neuroendocrine carcinomas with a comparison to colorectal adenocarcinomas

163例转移性结直肠神经内分泌癌的分子临床特征和治疗结果，并与结直肠腺癌进行比较

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.70367
Morken, Siren; Langer, Seppo W; Hjortland, Geir Olav; Sundlöv, Anna; Hofsli, Eva; Ladekarl, Morten; Tabaksblat, Elizaveta; Vestermark, Lene Weber; Svensson, Johanna; Knigge, Ulrich; Nunes, Luís; Glimelius, Bengt; Pfeiffer, Per; Aasebø, Kristine; Assmus, Jörg; Vassella, Erik; Lothe, Inger Marie Bowitz; Couvelard, Anne; Perren, Aurel; Knappskog, Stian; Sorbye, Halfdan
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study

一项前瞻性队列研究纳入了 639 例晚期高级别消化道神经内分泌肿瘤（NET G3 和 NEC），旨在探讨其特征和治疗结果。该研究为 NORDIC NEC 2 研究。

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-025-03054-w
Sorbye, Halfdan; Hjortland, Geir Olav; Vestermark, Lene Weber; Ladekarl, Morten; Svensson, Johanna; Sundlöv, Anna; Janson, Eva Tiensuu; Garresori, Herish; Hofsli, Eva; Kersten, Christian; Elvebakken, Hege; Pfeiffer, Per; Morken, Siren; Assmus, Jorg; Lothe, Inger Marie Bowitz; Tabaksblat, Elizaveta; Knigge, Ulrich; Couvelard, Anne; Perren, Aurel; Langer, Seppo W
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study

更正：一项前瞻性队列研究纳入639例晚期高级别消化道神经内分泌肿瘤（NET G3和NEC），探讨其特征和治疗结果。NORDIC NEC 2研究

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-025-03095-1
Sorbye, Halfdan; Hjortland, Geir Olav; Vestermark, Lene Weber; Ladekarl, Morten; Svensson, Johanna; Sundlöv, Anna; Janson, Eva Tiensuu; Garresori, Herish; Hofsli, Eva; Kersten, Christian; Elvebakken, Hege; Pfeiffer, Per; Morken, Siren; Assmus, Jorg; Lothe, Inger Marie Bowitz; Tabaksblat, Elizaveta; Knigge, Ulrich; Couvelard, Anne; Perren, Aurel; Langer, Seppo W
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Pancreatic neuroendocrine tumors and MUTYH pathogenic variants: a multinational study

胰腺神经内分泌肿瘤与MUTYH致病变异：一项多国研究

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251356335
Riechelmann, Rachel P; Torrezan, Giovana T; Bergsland, Emily; Raj, Nitya; Strosberg, Jonathan; Moon, Farhana; Felismino, Tiago C; Knappskog, Stian; Trevizani, Elena; Cingarlini, Sara; Sorbye, Halfdan
肿瘤
肿瘤免疫
MUTYH
发表日期：2025
文献求助 收藏

PRRT in high-grade digestive neuroendocrine neoplasms (NET G3 and NEC)

PRRT治疗高级别消化道神经内分泌肿瘤（NET G3和NEC）

期刊:Journal of Neuroendocrinology
影响因子:4.1
doi:10.1111/jne.13443
Sorbye, Halfdan; Kong, Grace; Grozinsky-Glasberg, Simona; Strosberg, Jonathan
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Controversies in NEN: An ENETS position statement on the treatment of patients with Grade 3 well-differentiated neuroendocrine tumours of the gastro-enteropancreatic tract

神经内分泌肿瘤（NEN）争议：欧洲神经内分泌肿瘤学会（ENETS）关于3级高分化胃肠胰神经内分泌肿瘤患者治疗的立场声明

期刊:Journal of Neuroendocrinology
影响因子:4.1
doi:10.1111/jne.70080
McNamara, Mairéad G; Sorbye, Halfdan; Begum, Nehara; Christ, Emanuel; Fazio, Nicola; Fernandez-Cuesta, Lynnette; Garcia-Carbonero, Rocio; Kaltsas, Gregory; Kasajima, Atsuko; Salazar, Ramon; Speel, Ernst Jan M; Kjaer, Andreas
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

KRAS and NRAS mutations in Nordic population-based and real-world metastatic colorectal cancer cohorts

北欧人群和真实世界转移性结直肠癌队列中的KRAS和NRAS突变

期刊:
影响因子:
doi:10.1038/s44276-025-00188-5
Osterlund, Emerik; Ristimäki, Ari; Nunes, Luís; Kytölä, Soili; Aho, Sonja; Heervä, Eetu; Uutela, Aki; Lehtomäki, Kaisa; Stedt, Hanna; Halonen, Päivi; Kontiainen, Joel; Muhonen, Timo; Kallio, Raija; Sundström, Jari; Ålgars, Annika; Ristamäki, Raija; Nieminen, Lasse; Sorbye, Halfdan; Pfeiffer, Per; Salminen, Tapio; Nordin, Arno; Lamminmäki, Annamarja; Mäkinen, Markus J; Sjöblom, Tobias; Isoniemi, Helena; Glimelius, Bengt; Osterlund, Pia
RAS
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial

一线奥沙利铂化疗联合纳武利尤单抗治疗转移性微卫星稳定型结直肠癌——随机METIMMOX试验

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-024-02696-6
Ree, Anne Hansen; Šaltytė Benth, Jūratė; Hamre, Hanne M; Kersten, Christian; Hofsli, Eva; Guren, Marianne G; Sorbye, Halfdan; Johansen, Christin; Negård, Anne; Bjørnetrø, Tonje; Nilsen, Hilde L; Berg, Jens P; Flatmark, Kjersti; Meltzer, Sebastian
肿瘤
肠癌
TIM
多发性骨髓瘤
肿瘤免疫
MET
发表日期：2024
文献求助 收藏

Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms

根据消化系统高级别神经内分泌肿瘤的基因改变和临床特征进行治疗的结果

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-024-02773-w
Elvebakken, Hege; Venizelos, Andreas; Perren, Aurel; Couvelard, Anne; Lothe, Inger Marie B; Hjortland, Geir O; Myklebust, Tor Å; Svensson, Johanna; Garresori, Herish; Kersten, Christian; Hofsli, Eva; Detlefsen, Sönke; Vestermark, Lene W; Knappskog, Stian; Sorbye, Halfdan
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏